Bioassay-guided isolation and structure elucidation of anti-mycobacterium tuberculosis compounds from Galatella grimmii (Regel & Schmalh.) Sennikov
- PMID: 39354550
- PMCID: PMC11443940
- DOI: 10.1186/s12906-024-04632-w
Bioassay-guided isolation and structure elucidation of anti-mycobacterium tuberculosis compounds from Galatella grimmii (Regel & Schmalh.) Sennikov
Abstract
Background: Galatella is a genus in the family Asteraceae, represented by 35-45 species. Considering the high effectiveness of the ethyl acetate (EtOAc) fraction of G. grimmii against Mycobacterium tuberculosis (MIC = 0.5 µg/mL), a bioassay-directed fractionation of this extract was carried out.
Methods: The methanolic extract of the aerial parts of G. grimmii was obtained using maceration, then it was suspended in water and partitioned with petroleum ether, dichloromethane (CH2Cl2), EtOAc, and n-butanol (n-BuOH), successively. The most potent fraction (EtOAc), was selected for further isolation by Sephadex LH-20 and semi-preparative HPLC to obtain active compounds.
Results: Fractionation of the EtOAc solvent fraction resulted in the characterization of five compounds, among them, compounds 1 and 2 showed the highest anti-mycobacterial effects with MICs of 0.062 and 1.00 µg/mL against H37Rv M. tuberculosis, respectively, which were higher than those of rifampin (MIC of 1.25 µg/mL) and isoniazid (MIC of 0.31 µg/mL), as positive controls. Also, compound 1 inhibited all tested strains of drug-resistant Mycobacterium (MDR and XDR). Notably, the isolated compounds have been reported for the first time from G. grimmii.
Conclusion: Due to the potent anti-mycobacterial effect of isolated compounds from G. grimmii, this study could pave the way for developing a novel class of natural anti-tuberculosis compounds.
Keywords: Galatella; Mycobactrium Tuberculosis; Bioassay-guided fractionation; Flavonoids; NMR.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Anti-mycobacterial Activity of 22 Iranian Endemic or Rare Plant Extracts Against Multi-drug and Extensively Drug-resistant Mycobacterium tuberculosis.Comb Chem High Throughput Screen. 2022;25(5):870-876. doi: 10.2174/1386207324666210215100931. Comb Chem High Throughput Screen. 2022. PMID: 33588723
-
Isolation and characterization of antimicrobial compounds from Terminalia phanerophlebia Engl. & Diels leaf extracts.J Ethnopharmacol. 2014 Oct 28;156:228-34. doi: 10.1016/j.jep.2014.09.003. Epub 2014 Sep 16. J Ethnopharmacol. 2014. PMID: 25218320
-
Optimisation of the microplate resazurin assay for screening and bioassay-guided fractionation of phytochemical extracts against Mycobacterium tuberculosis.Phytochem Anal. 2014 Sep-Oct;25(5):461-7. doi: 10.1002/pca.2516. Epub 2014 Apr 14. Phytochem Anal. 2014. PMID: 24733665
-
Antimycobacterial activity of Citrullus colocynthis (L.) Schrad. against drug sensitive and drug resistant Mycobacterium tuberculosis and MOTT clinical isolates.J Ethnopharmacol. 2013 Aug 26;149(1):195-200. doi: 10.1016/j.jep.2013.06.022. Epub 2013 Jun 29. J Ethnopharmacol. 2013. PMID: 23816500
-
Evaluation of the antimycobacterium activity of the constituents from Ocimum basilicum against Mycobacterium tuberculosis.J Ethnopharmacol. 2012 Oct 31;144(1):220-2. doi: 10.1016/j.jep.2012.08.003. Epub 2012 Aug 17. J Ethnopharmacol. 2012. PMID: 22982011
References
-
- Tuberculosis. Https://www.who.int/news-room/fact-sheets/detail/tuberculosis. 2022.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources